Do antipsychotics cause erectile dysfunction? Yes, antipsychotic medications can cause erectile dysfunction (ED) as a recognised adverse effect. Sexual difficulties, including problems achieving or maintaining an erection, affect a substantial proportion of men taking these drugs, though rates vary widely depending on the specific medication, dose, and individual factors. The psychiatric conditions for which antipsychotics are prescribed—such as schizophrenia and bipolar disorder—can themselves contribute to sexual dysfunction, making the relationship complex. Understanding the mechanisms, identifying higher-risk medications, and exploring management strategies can help balance mental health stability with sexual wellbeing.

Do Antipsychotics Cause Erectile Dysfunction?

Yes, antipsychotic medications can cause erectile dysfunction (ED) as a recognised adverse effect. Sexual dysfunction, including difficulties achieving or maintaining an erection, affects a substantial proportion of men taking antipsychotic drugs, though rates vary widely depending on the specific medication, dose, and individual factors. However, the relationship is complex and not solely attributable to medication.

It is important to recognise that the psychiatric conditions for which antipsychotics are prescribed—such as schizophrenia, bipolar disorder, and severe depression—can themselves contribute to sexual dysfunction. Symptoms including low mood, reduced motivation, and altered self-perception may independently affect sexual desire and performance. Consequently, distinguishing between medication-related effects and illness-related factors can be challenging in clinical practice and requires careful assessment by your healthcare team.

The mechanism by which antipsychotics cause erectile dysfunction primarily involves their effects on neurotransmitter systems, particularly dopamine and prolactin pathways. Many antipsychotics block dopamine D2 receptors, which can lead to elevated prolactin levels (hyperprolactinaemia). Raised prolactin suppresses testosterone production and directly impairs erectile function. Additionally, some antipsychotics have anticholinergic, antihistaminic, and alpha-adrenergic blocking properties that may further contribute to sexual difficulties. Rarely, certain antipsychotics (particularly those with alpha-1 blocking effects) may cause priapism—a prolonged, painful erection lasting more than four hours that requires emergency medical attention.

Whilst erectile dysfunction is a genuine concern for many men taking antipsychotics, it is crucial not to discontinue medication without medical guidance. Abrupt cessation can lead to relapse of serious mental health symptoms. Open communication with healthcare professionals enables appropriate management strategies that balance mental health stability with quality of life, including sexual wellbeing. If you experience sexual side effects, you are encouraged to report them via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.

How Antipsychotic Medications Affect Sexual Function

Antipsychotic medications influence sexual function through multiple pharmacological mechanisms. The most significant pathway involves dopamine receptor blockade, which is central to the therapeutic action of these drugs but also responsible for many sexual side effects. Dopamine plays a crucial role in sexual arousal and desire; its inhibition can reduce libido and impair the physiological processes necessary for achieving an erection.

Hyperprolactinaemia represents one of the most clinically significant mechanisms. Many antipsychotics, particularly first-generation (typical) agents and some second-generation (atypical) drugs such as risperidone and amisulpride, cause substantial elevation in serum prolactin levels. Prolactin elevation suppresses the hypothalamic-pituitary-gonadal axis, reducing luteinising hormone (LH) and follicle-stimulating hormone (FSH) secretion, which in turn decreases testosterone production. Low testosterone is directly associated with reduced sexual desire and erectile difficulties. Men may also experience other symptoms of hyperprolactinaemia including gynaecomastia (breast tissue enlargement), galactorrhoea (inappropriate nipple discharge), reduced bone density, and infertility. Persistent hyperprolactinaemia warrants clinical assessment and, where appropriate, monitoring.

Additional pharmacological effects contribute to sexual dysfunction. Alpha-1 adrenergic receptor antagonism, present in medications such as quetiapine, chlorpromazine, and clozapine, is particularly associated with ejaculatory dysfunction and, rarely, priapism (a prolonged, painful erection requiring emergency treatment). Anticholinergic properties may reduce parasympathetic activity necessary for vasodilation and erection. Antihistaminic effects can cause sedation and reduced arousal, indirectly affecting sexual performance.

The serotonergic system also plays a role, though this is more complex. Some antipsychotics with serotonin receptor activity may influence sexual function, though the effects vary depending on which specific serotonin receptor subtypes are affected. Understanding these mechanisms helps clinicians identify which patients are at higher risk and guides medication selection and management strategies.

Which Antipsychotics Are Most Likely to Cause Erectile Problems?

The risk of erectile dysfunction varies considerably across different antipsychotic medications, primarily related to their propensity to elevate prolactin levels and their receptor binding profiles. First-generation (typical) antipsychotics generally carry a higher risk of sexual dysfunction compared to many second-generation agents. Medications such as haloperidol and chlorpromazine are associated with significant dopamine D2 receptor blockade and consequent hyperprolactinaemia, making erectile difficulties relatively common.

Among second-generation (atypical) antipsychotics, there is considerable variation. Risperidone and amisulpride are particularly associated with elevated prolactin levels and sexual dysfunction, with rates comparable to or sometimes exceeding those seen with typical antipsychotics. Risperidone's potent D2 receptor antagonism results in dose-dependent prolactin elevation, and sexual side effects are frequently reported at therapeutic doses. Paliperidone, the active metabolite of risperidone, shares similar properties and risks.

Olanzapine presents a moderate risk, with sexual dysfunction reported but generally at lower rates than risperidone. Its broader receptor binding profile includes significant anticholinergic and antihistaminic effects, which may contribute to sexual difficulties through different mechanisms. Quetiapine is associated with relatively lower rates of sexual dysfunction and minimal prolactin elevation at standard doses, though its alpha-adrenergic blocking properties may still affect some patients.

Aripiprazole is considered to have one of the most favourable profiles regarding sexual side effects. As a partial dopamine agonist rather than a pure antagonist, it typically does not elevate prolactin and may even reduce prolactin levels in patients switching from other antipsychotics. Similarly, cariprazine, which shares partial agonist properties, appears to have a lower risk of sexual dysfunction. Clozapine, despite its efficacy in treatment-resistant schizophrenia, can cause sexual dysfunction through multiple mechanisms including anticholinergic effects and, rarely, priapism, though prolactin elevation is generally modest. Individual responses vary, and the choice of antipsychotic should balance efficacy, tolerability, and individual risk factors in consultation with your psychiatrist or GP.

Managing Erectile Dysfunction Whilst Taking Antipsychotics

Effective management of antipsychotic-induced erectile dysfunction requires a collaborative approach between patient and healthcare team, balancing mental health stability with quality of life. Several evidence-based strategies can be considered, tailored to individual circumstances.

Medication review and adjustment represents the first-line approach when sexual dysfunction emerges. If clinically appropriate and the patient's mental health is stable, switching to an antipsychotic with a lower propensity for sexual side effects may be considered. For example, transitioning from risperidone to aripiprazole or quetiapine might reduce erectile difficulties whilst maintaining therapeutic benefit. However, any medication change must be carefully supervised, as switching antipsychotics carries risks of symptom relapse or emergence of different side effects. Dose reduction may also be explored if the patient is receiving higher than necessary doses, though this must not compromise psychiatric stability.

Before initiating specific treatments, a thorough assessment is essential. Your GP or psychiatrist should review your full medication list (including over-the-counter and recreational substances), assess cardiovascular risk factors, and arrange appropriate investigations. These typically include blood tests for HbA1c or fasting glucose, lipid profile, and morning (9 a.m.) total testosterone. If testosterone is low, repeat testing with sex hormone-binding globulin (SHBG), LH, and FSH may be indicated. Prolactin levels should be checked where hyperprolactinaemia is suspected. Thyroid function tests may be considered if clinically indicated.

Adjunctive pharmacological treatments can address erectile dysfunction directly. Phosphodiesterase-5 (PDE5) inhibitors such as sildenafil, tadalafil, or vardenafil are effective treatments for erectile dysfunction and can be used alongside most antipsychotics. These medications enhance erectile function by promoting blood flow to the penis. However, important safety considerations apply: PDE5 inhibitors are contraindicated in men taking nitrates (due to risk of severe hypotension); caution is required in those taking alpha-blockers or experiencing antipsychotic-induced orthostatic hypotension; and vardenafil in particular may prolong the QT interval, requiring careful review of other QT-prolonging medications. Treatment should start at the lowest effective dose, and individual Summary of Product Characteristics (SmPCs) should be consulted. Prescribing follows standard contraindication screening, particularly regarding cardiovascular status.

When hyperprolactinaemia is confirmed through blood testing and causing troublesome symptoms, specific interventions may be warranted. If prolactin levels are significantly elevated, adjunctive low-dose aripiprazole (a partial dopamine D2 agonist antipsychotic) may be added to the existing regimen to reduce prolactin, though this approach requires specialist guidance. Alternatively, switching to a prolactin-sparing antipsychotic may normalise levels. Dopamine agonists such as cabergoline or bromocriptine are occasionally used under specialist endocrinology or psychiatry supervision, but carry a risk of worsening psychosis and are not routinely recommended in this context.

Referral to specialist services may be appropriate in certain circumstances: urgent referral is required for priapism lasting more than four hours, or for symptoms suggesting a pituitary mass (new visual disturbance, severe persistent headache, particularly with galactorrhoea); routine endocrinology referral is indicated for persistent, marked hyperprolactinaemia; urology or sexual health services may be consulted if erectile dysfunction is refractory to initial management or if diagnostic uncertainty exists; and cardiology review may be needed if cardiovascular risk is high.

Lifestyle modifications support overall sexual health and erectile function. Encouraging regular physical activity, maintaining a healthy weight, limiting alcohol consumption, stopping smoking, and managing cardiovascular risk factors (hypertension, diabetes, hyperlipidaemia) all contribute to improved erectile function. Psychological support, including psychosexual counselling or cognitive behavioural therapy, may help address anxiety or relationship difficulties that compound medication-related effects.

When to Speak to Your Doctor About Sexual Side Effects

Open communication with healthcare professionals about sexual side effects is essential but often overlooked. Many patients feel embarrassed discussing erectile dysfunction or assume nothing can be done, leading to silent suffering and, in some cases, non-adherence to prescribed medication. It is important to recognise that sexual health is a legitimate component of overall wellbeing, and healthcare professionals are accustomed to discussing these concerns in a sensitive, non-judgemental manner.

You should contact your GP or psychiatrist if:

• You experience new or worsening erectile difficulties after starting or increasing an antipsychotic medication

• Sexual dysfunction is affecting your quality of life, self-esteem, or relationships

• You are considering stopping your medication due to sexual side effects

• You notice other symptoms that may indicate hyperprolactinaemia, such as breast enlargement, nipple discharge, reduced facial or body hair growth, or decreased libido

• Erectile dysfunction is accompanied by other concerning symptoms

Seek emergency medical attention immediately if you experience an erection lasting more than four hours (priapism), severe chest pain or shortness of breath, or new visual disturbance or severe persistent headache (particularly if accompanied by galactorrhoea or other symptoms suggesting a pituitary problem).

Timing matters: whilst some sexual side effects may improve with time as the body adjusts to medication, if symptoms persist for a few weeks or are troublesome at any time, seek medical review rather than waiting for spontaneous resolution.

Prepare for the consultation by noting when symptoms began, their severity, and any patterns you have observed. Bring a complete list of all medications, including over-the-counter products and any recreational substances, and note the timing of symptoms relative to dose changes. Be honest about the impact on your life—this information helps clinicians understand the urgency and guides management decisions. If you find face-to-face discussion difficult, consider writing down your concerns or requesting a telephone consultation initially.

Never discontinue antipsychotic medication abruptly without medical supervision due to sexual side effects. Sudden cessation can precipitate serious relapse of psychiatric symptoms, including psychosis, mood instability, or suicidal thoughts. Your healthcare team can explore safer alternatives, including medication adjustment, adjunctive treatments, or specialist referral to services experienced in managing medication-related sexual dysfunction. Remember that effective solutions often exist, and addressing these concerns openly is an important step towards maintaining both mental health and sexual wellbeing.

If you experience side effects from your antipsychotic medication, you can report them via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or by searching for 'Yellow Card' in the Google Play or Apple App Store. Reporting helps improve the safety of medicines for everyone.

Frequently Asked Questions